Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
Condition:   Hemophilia Intervention:   Drug: Fitusiran Sponsor:   Genzyme, a Sanofi Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2019 Category: Research Source Type: clinical trials

Lentiviral FIX Gene Therapy
Condition:   Hemophilia B Intervention:   Biological: YUVA-GT-F901 Sponsor:   Shenzhen Geno-Immune Medical Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2019 Category: Research Source Type: clinical trials

rFVIIIFc (Elocta ®) ITI Chart Review in Patients With Haemophilia A
Condition:   Hemophilia A With Inhibitor Intervention:   Other: rFVIIIFc Sponsors:   Swedish Orphan Biovitrum;   Kantar Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
Condition:   Hemophilia A Intervention:   Drug: Recombinant Human Coagulation FVIII Sponsor:   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials